Doxorubicin (Doxorubicin Ebewe) inj 2 mg per ml: Supply issue

Supply issue Active

Sandoz has notified us of a supply issue with doxorubicin inj 2 mg per ml, 100 ml vial (pharmacode 2224100) and inj 2 mg per ml, 25 ml vial (pharmacode 2224089).

About the affected product

The supply issue has been caused by a manufacturing issue.

Doxorubicin

  • Brand: Doxorubicin Ebewe 
  • Presentation: inj 2 mg per ml, 100 ml vial 
  • Pharmacode: 2224100
  • Supply status: out of stock
  • Brand: Doxorubicin Ebewe 
  • Presentation: inj 2 mg per ml, 25 ml vial 
  • Pharmacode: 2224089
  • Supply status: limited availability

Schedule listings for doxorubicin(external link)

HML listings for doxorubicin(external link)

Resupply expected mid-April 2023

Sandoz advises that they expect Doxorubicin Ebewe inj 2 mg per ml, 100 ml vial - will be available again by mid-April 2023.

Alternative products

We are currently working on sourcing alternatives.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.  

Sign up to our email list for regular emails about supply issues and more(external link)